Cash can reach investors before the business pays for itself

1. The answer: real realization, different claims, no automatic validation of the next price

The evidence supports genuine cash realization and productive capital recycling more strongly than an “all paper gains” account. It does not establish that every recipient earned the same investment return, that customer profits supplied the money, or that the next buyer paid a justified price. The distinction is observable in completed transactions, not merely hypothetical.

CoreWeave's March 2025 base IPO was predominantly new company funding: the reconstructed allocation puts $1.4226192 billion with the issuer and $35.3808 million with selling holders, after underwriting but before other expenses. The three co-founder groups sold no shares in that IPO's selling-holder table. They had, however, already received a combined $487.855191 million of reported gross consideration in the December 2023 and October 2024 tenders. “The IPO was mainly an insider exit” and “the founders had not realized cash” therefore both miss the transaction record. These are gross group receipts, not personal after-tax investment gains.[P][Q1]

A named employee transaction shows how to go one step further without inventing a complete tax basis. Kristen McVeety's December 2023 tender consideration, less the explicitly disclosed contemporaneous option-exercise remittance, leaves $1,247,692 before other transaction costs and tax. This is a realized cash spread with a documented deduction. Dividing it by the exercise remittance would not measure the return on all the time, compensation and risk embodied in the option.

The surviving claim also matters. Conversion at the IPO did not immediately make every Class A share economically identical: a Series C-derived block retained a put and a minimum company-sale consideration right. The new allocation test shows how that right could have redistributed $566.114 million from other common holders at a stipulated low equity-sale value. The right actually terminated in September 2025. This is a historical rights comparison, not a present redemption bill, a predicted sale or a loss that occurred. The termination removed a contingent claim without paying its face amount in cash.[P][Q3]

Core Scientific supplies a different mechanism. Its May 2026 notes financed an actual exit for the old bridge claim and permitted a distribution to the corporate parent. The new lenders acquired a secured claim on future project resources; the parent retained completion responsibilities. That is a refinancing and capital-allocation event, not a public-shareholder dividend or new customer revenue. The source-and-use calculation identifies a substantial conditional parent-resource remainder, while refusing to call a June reserve stock an observed May closing deposit.[CLOSE][IND][CSQ]

The whole-question update is consequently more specific than “AI is useful but uncertain.” Early owners can realize cash, lenders can be repaid, and a company can remove expensive or restrictive claims before the operating business is self-financing. Those outcomes are favorable evidence about financing and realization. The unresolved investment question moves to the price and obligations accepted by the remaining owners and creditors, and to whether completed, adequately priced service produces enough cash after all continuing costs. The completion, buyer-budget and full-cost service investigations make those operating conditions concrete; neither a successful exit nor a conditional floor settles them.

2. The completed ownership transaction: follow each payment rather than the offering headline

2.1 Event, recipient and evidence strength

The principal public case is the completed March 2025 CoreWeave IPO, read through its final prospectus and subsequent quarterly accounts, with the completed 2023/2024 tenders providing the earlier-owner comparison. The final prospectus is dated March 27 and specifies expected delivery on or about March 31. The March-quarter accounts establish completion and receipt by quarter-end; the precise settlement time and individual sellers' bank entries were not obtained. April's partial over-allotment is a later event, not cash available at the March closing.[P][Q1]

The public purchasers bought Class A shares. Underwriters contractually took the offering for resale; their underwriting allotments do not establish their later retained investment positions. The distinction between company and seller proceeds survives the use of intermediaries. A seller exchanges a claim for cash. The issuer creates an additional claim and receives cash. Neither transaction is an operating sale of computing service.

Source terms: final prospectus cover and underwriting table. Calculations: the downloadable companion’s offering function. Subsequent issuer cash accounts corroborate the primary net to their $1,000 reporting precision. The seller column is the settlement allocation under the completed offering, not a separate bank-statement audit.

The primary fraction is 97.5733%. For every $100 paid at this offering's terms, $2.80 is underwriting compensation and $97.20 goes to the relevant issuer or selling holder before other expenses. It cannot go to both. Underwriting compensation is not the underwriter's net profit: its own distribution and operating costs are outside this account.

2.2 Actual cost versus a prospective estimate

The prospectus estimated roughly $26 million of issuer offering expenses excluding underwriting. The subsequent equity statement records $1.391515 billion for the IPO after underwriting and offering costs. Comparing that with the cash statement's rounded $1.422619 billion net-underwriting line reconstructs $31.104 million of other deal costs, not the earlier estimate.[P][Q1]

The cash timing is different again. Q1 reports $16.870 million of deferred offering costs paid and $11.899 million not yet paid. On a matching whole-deal cost basis, the remaining $2.335 million is a reconciliation amount attributable to earlier payment or another cost-timing allocation:

$31.104m − $16.870m − $11.899m = $2.335m.

The documents inspected do not provide a complete invoice roll-forward establishing the exact identity of that remainder. It is not another October payable or a new unexplained cash loss. Most importantly, the $31.104 million accrual cost and the $16.870 million quarterly payment are not two independent expenses to deduct from the same proceeds. One describes the deal's recognized cost; the other describes part of when cash was paid.

2.3 The proceeds did not remain an untouched cash pile

The matched March-quarter account, including restricted cash, is:

$2,035.833m opening cash + $61.168m operating cash − $1,433.051m investing cash + $1,853.866m financing cash = $2,517.816m ending cash.

Within financing, the signed components are $784.956m debt issuance, −$271.104m debt repayments, −$26.101m preferred cash dividends, +$2.794m option exercises, +$1,422.619m IPO receipts, −$15.685m award tax withholding, −$16.870m offering-cost payments and −$26.743m other financing. The companion conserves this cash without inserting the secondary sellers' receipts or the noncash customer shares.[Q1]

Only $1,276.456 million of the ending total was unrestricted cash and equivalents; the rest was classified as restricted. Included within that restricted pool was the IPO-related $500 million DDTL 2.0 escrow requirement. Its restriction was lifted in April. Release made existing cash more usable; it did not collect another $500 million from customers or investors.[Q1][Q2]

The $1 billion 2024 Term Loan was repaid on April 11, following IPO-triggered acceleration. Its principal was therefore still a claim at March 31 and disappeared through the later repayment. The March cash-flow debt-repayment line cannot be described as already containing that April billion. Conversely, an analysis after repayment must not keep the retired principal as a second outstanding claim.[Q1]

Operating cash less cash property/equipment and capitalized-software purchases was −$1.346191 billion in Q1. That establishes that these particular current cash uses exceeded operating cash in the period; it does not establish a negative lifetime investment return. Financing can sensibly pay for an asset before that asset earns. The matched account nevertheless rules out calling the IPO resource independently earned operating cash.

The prospectus's proposed uses included debt repayment, tax withholding and escrow, supplemented by existing cash where necessary. There is no valid inference that each use must fit inside IPO proceeds alone. Nor can this consolidated account trace a particular customer's dollar into a particular investor's exit. Cash is fungible once inside the same unrestricted account, while restrictions and contractual uses can still identify important parts of its allocation.

2.4 Noncash customer consideration is neither primary cash nor seller cash

The concurrent 8.75 million shares issued to OpenAI, initially valued at $350 million, were a customer-contract incentive. They were not a $350 million cash subscription. The accounts explicitly identify noncash consideration. Excluding it from cash sources is not a claim that the commercial agreement had no value: the company exchanged equity for a business relationship whose ultimate net value requires service delivery, collections and complete costs.[Q1]

This is materially different from NVIDIA's January 2026 primary share purchase described in the holder investigation. NVIDIA's purchase supplied company funding; OpenAI's share grant did not supply that cash leg. The instruments and dates cannot be merged merely because both counterparties also participate in the AI supply chain. Neither event is the separately qualified NVIDIA–Energy Global prepaid forward.[HOLDER][PRIOR]

2.5 Two smaller reconciliations prevent false precision

April option. Only 1.76 million additional primary shares were actually purchased, not the maximum 5.625 million authorized. Applying the base $38.88 net price mechanically gives $68.4288 million. The later equity and cash-flow statements instead report $67.669 million, while the narrative rounds to $68 million. The $759,800 difference is unresolved in the inspected record. This chapter uses the reported cash amount, preserves the terms-only comparison separately, and does not invent a fee recipient or silently change the subscription price.[Q2]

Preferred dividend timing. Q1's cash statement reports $26.101 million paid; its equity statement records $28.693 million and its note rounds cash dividends to $29 million. H1's cash statement reports $28.693 million cumulatively, but the H1 note says no dividends were paid during Q2. Subtracting the two cash statements gives $2.592 million, which cannot safely be assigned a Q2 payment date while ignoring the note. The half-year cumulative amount is documented; the precise quarter allocation remains unreconciled. It is neither evidence of nonpayment nor authority to add two “$29 million” dividends. The special preferred dividend ended on conversion and is distinct from a dividend on public common shares.[Q1][Q2]

These discrepancies do not undo the completed IPO. They identify where a reproducible allocation is firmer than an assertion about an exact expense recipient or day of payment.

3. Who had already received cash—and what “return” can actually be measured

3.1 The founder groups' earlier exits

The final prospectus retrospectively reports completed tender transactions. In December 2023, buyers acquired outstanding claims at a stated split-adjusted $15.50 reference price; October 2024's corresponding reference was $47. The disclosed dollar consideration is used directly because multiplying rounded per-share prices by shares does not always reproduce it.[P]

These are realized secondary-sale receipts at the disclosed group perimeter. They are not entirely money retained personally by three individuals, not a tax calculation, and not the holders' total realized investment gain. Acquisition basis, some exercise payments, taxes, transaction expenses and subsequent investments are not fully disclosed. No cost basis is set to zero.

The buyers supplied the sale consideration; CoreWeave did not receive those secondary sale proceeds. It did receive $354,436 of employee option-exercise remittances associated with the 2023 tender. That small issuer inflow belongs in its own category. Treating the entire tender as company funding would overstate cash available to construct and operate capacity.

The favorable interpretation is substantial: early holders could diversify concentrated exposure and convert a risky claim into spendable resources while new owners voluntarily financed the ownership transfer. The adverse interpretation is also real but narrower than wrongdoing: a later owner can absorb losses after an earlier seller has already realized cash. The existence of that separation is established; whether the new price fairly compensated for the remaining risk is a different question.

3.2 A named cash spread with an actual disclosed deduction

For Kristen McVeety's December 2023 tender, the source reports 83,480 shares and $1,293,356 gross consideration. Footnote 4 explicitly includes $45,664 remitted to CoreWeave for the contemporaneous net exercise of employee stock options. Therefore:

$1,293,356 − $45,664 = $1,247,692.

This is the amount remaining after that identified exercise payment and before other sale expenses and taxes. It demonstrates why gross consideration is not the amount the seller can retain. It also demonstrates why an exercise price is not automatically a complete investment cost basis: the option was part of an employment and vesting arrangement, with earlier service, tax treatment and risk not priced by this subtraction.[P]

At the subsequent IPO, the selling-holder record allocates McVeety 74,460 shares. At the completed offering terms, that is $2,978,400 gross, or $2,895,004.80 after underwriting, before other holder costs and tax. The record gives 1,497,480 post-offering beneficial shares, a dated pro-forma beneficial-ownership quantity that can include qualifying exercisable securities—not an October 2026 liquid position or a cash receipt. The old $45,664 exercise payment is not carried over as the basis of this different lot.

For comparison, the same allocation produces $6,160,147.20 for Max Hjelm's 158,440 IPO shares and $494,553.60 for Nitin Agrawal's 12,720 shares after underwriting. These calculations identify recipients and the applicable deduction without pretending to know their complete gains. They are included within, not additional to, the $35.3808 million seller total.[P]

One source row is deliberately excluded from return arithmetic. The October 2024 tender lists McVeety's 135,660 shares and $5,257,701 gross consideration, which does not match the stated $47 reference price. No inspected footnote supplied a reconciliation. The data labels that row a source conflict; it is not “fixed” by inventing an exercise deduction or silently substituting a different price. The well-specified December transaction and the IPO remain sufficient for the recipient account.

3.3 A documented buyer basis is not a documented buyer exit

Fidelity-affiliated entities paid $310,000,057 for 20,009,040 shares in the completed December 2023 tender. The effective cash consideration is therefore about $15.493 per share, slightly different from the rounded $15.50 headline. This is an acquisition cost for the disclosed group, not a realized profit. Other purchases—including its separately disclosed Series C subscription and later tender activity—must not be assigned the same basis or rights.[P]

The historical-rights comparison uses this exact acquisition cost to ask what a hypothetically retained specified lot would receive under the same remaining-business outcomes faced by a new $40 IPO buyer. It does not assert that Fidelity still held that precise lot, sold it at a modeled price, or distributed any resulting money to its own fund investors. Fund-level expenses, carried interests, taxes and distribution timing would be additional necessary evidence for an LP or mutual-fund investor's realized result.

3.4 Preserve GECC's actual gains without manufacturing the missing upstream transaction

The holder investigation established $9.5 million cumulative distributions against an original $6 million LP investment, alongside a June 2026 retained interest with $3.351 million cost and $6.147 million fair value. The cash exceeded the original outlay by $3.5 million. That is genuine favorable realization; uncertainty about its upstream source does not make the cash fictitious.[HOLDER]

It is still not a complete IRR, a tax characterization of distributions, or proof that operating profits alone paid them. The distribution dates, private portfolio transactions, expenses and changes in tax/cost basis were not obtained. Nor is the historical $9.5 million added to current liquidity, or deducted from the $6.147 million still exposed to a new mark. The LP unit is not a direct CoreWeave share and is not identified as holding Core Scientific's notes. This chapter uses the public transactions above rather than making the private LP register a dependency.

4. The right that survived conversion—and then actually disappeared

4.1 “Class A” did not initially mean the same downside claim

The Series C financing combined equity participation with a special redemption arrangement. At the IPO, its preferred shares converted, including the effect of the specified dividend/conversion mechanics, into 29,874,066 redeemable Class A shares. The other preferred conversion and the new public shares did not all inherit that arrangement. The relevant legal description gives a Series C original issue price of $38.95; the related-party financing narrative rounds its subscription reference differently, to $38.96. This chapter uses the legal $38.95 term for the right, not the narrative rounding to manufacture an exact original investment gain.[P][Q1]

While it remained alive, the right had two economically different routes. A holder could exercise the put at the specified Public Sale Date—the earlier of August 15, 2029 and the applicable second-IPO-anniversary date, subject to the trading-day provision. Alternatively, a company sale before that date and before the termination event entitled eligible holders to the greater of the ordinary per-share sale consideration and the Series C original issue price. This second route supplies the bounded allocation calculation below.

The put was not a cash balance or an unconditional public-market price floor. Exercise would generate an unsecured Put Note senior in payment to equity, due 15 days after the Public Sale Date. Its interest began at 10%, compounded quarterly, and increased to 14% if the principal was not paid when specified. The shares went into escrow; proceeds from their liquidation were credited against the note. A model cannot give the investor the full note repayment and a separate unrestricted sale of the same shares without that credit. The company-sale branch below therefore does not add a Put Note as a second claim.[P]

Public resale also extinguished the right on the affected shares. The arrangement thus could offer meaningful protection to an eligible continuing holder without transferring that protection to every public purchaser. A transaction at the same quoted “common share” price could exchange economically different rights. This is why a preferred financing price is not automatically an ordinary-common valuation.

4.2 Later execution changes the interpretation, not the historical record

Automatic termination required the stock's 20-day volume-weighted average price within a consecutive 30-trading-day period to reach at least 175% of the Series C original issue price, within the specified eligible window when the Coatue lock-up condition no longer prevented the test. The arithmetic threshold is $68.1625 from the displayed $38.95 term; the subsequent filing reports it rounded as $68.16. The lock-up and measurement-window conditions matter: merely seeing one high traded price would not establish termination.[P]

The June 2025 accounts stopped accretion because redemption was no longer considered probable, but continued to present the redeemable shares. That accounting assessment was not itself cancellation. The September 2025 accounts then explicitly report that the put automatically terminated in September, followed by reclassification into ordinary stockholders' equity.[Q2][Q3]

This is concrete favorable evidence of a completed removal of a contingent financing claim. It is not a roughly $1.2 billion cash payment, an equivalent operating profit, or an observed shareholder distribution. Nor should an October 2026 analysis still charge the company that terminated put. The historical calculation remains useful precisely because it shows what changed when the right ended; it is not a claim that those downside protections remain available today.

4.3 A new return-allocation calculation with a conserved equity sale budget

The calculation freezes the March 31, 2025 capital structure to isolate the historical right. The balance sheet reports 317.431 million ordinary Class A shares outstanding and 118.102 million Class B shares, separately from the redeemable block. Rounding the total consistently with the statement's thousand-share presentation gives 465.407 million shares. Treasury shares are excluded; the redeemable block is counted once. The prospectus's different, earlier pro-forma denominator is not substituted for the actual quarter-end structure.[Q1]

Let N = 465,407,000, protected shares P = 29,874,066, and the contractual floor K = $38.95. Let E be an all-in equity purchase budget after all non-equity claims and transaction costs. Any investment still needed to deliver the assumed business value must already be reflected in that budget. It is not enterprise value, accounting assets, a current market capitalization or cash available before lenders are paid.

For a solvent company sale while the historical right was live:

• If E/N is at least K, every share receives E/N under this simplified cash-right comparison.
• If P × K ≤ E < N × K, protected holders receive P × K, and the remaining common receives (E − P × K)/(N − P) per share.
• Below P × K, the function rejects the calculation. It does not invent bankruptcy priorities, recoveries or the enforceability of an underfunded transaction.

The comparison without the right distributes E/N to all shares. It holds both E and the share count fixed: only the right changes. This is not an estimate of September's actual capitalization or of the market value created by the termination.

Illustrations, not appraisals, forecasts or observed sales. The references are one-half, equal to and one-and-a-half times the IPO entry price. They expose the contractual breakpoint; no probability or operating forecast is assigned. Nominal results exclude investor fees and taxes and are not annualized.

At the low reference, the protected block receives $1,163,594,870.70, compared with $597,481,320 if all shares simply receive $20. The difference is $566,113,550.70, borne by the remaining common within the same purchase budget. This is a redistribution, not additional business revenue. The calculated floor amount uses the displayed rounded legal price; it should not be forced to equal an accounting carrying amount with its own accretion and precision conventions.

The documented December 2023 Fidelity lot demonstrates why entry basis matters even after equalizing ordinary-share rights. At $18.7002 per ordinary share, a hypothetically retained lot with its disclosed approximately $15.493 cash basis would have a +20.70% nominal gain, while the $40 IPO buyer would lose 53.25%. Without the put, the same stipulated $20 outcome yields approximately +29.09% for that earlier lot and −50% for the IPO buyer. These are conditional results on a specified lot, not observed Fidelity sales or investor distributions. The source does not establish their holding period through an actual modeled exit, so an IRR would be misleading.

This illustrates a central answer to the pool's question: an early investor's genuine success can coexist with a disappointing later investment in the same operating business. Different entry prices are enough; special rights can widen the difference. Conversely, at the higher stipulated value both investors can earn positive nominal returns. The allocation mathematics does not require a later buyer to lose or assume that the original investor's favorable outcome was improper.

5. What the offering did not remove

5.1 Funding can dilute a percentage without destroying its value

The IPO replaced preferred forms, supplied cash and broadened transferable ownership. It did not remove the company's loans, leases, service-delivery costs or commitments. The April debt repayment and escrow release changed particular claims and availability; neither established that all later investment could be funded internally. The customer-contract shares and outstanding employee securities also matter to who eventually shares the residual.[Q1][Q2]

A lower ownership percentage is not, by itself, a loss of wealth. Suppose a business worth V before new financing has N identical shares, and issues n identical shares at the fair pre-financing price V/N, without fees or changed operating prospects. Its post-financing value is V + nV/N; an old holder's proportion falls, but the value per old share remains V/N. Underpricing, transaction costs, unequal rights or a poor use of the new resources can change that result. This identity explains dilution; it does not assert that CoreWeave's $40 issue was a demonstrated fair price.

Likewise, cash used to pay tax withheld on awards is a financing use and part of the employee-equity arrangement, not another public investor distribution. Outstanding options, warrants and unvested awards need their own exercise, vesting and settlement treatment. The quarter's warrant-equity reclassification is not cash received by a warrant holder. The 2025 incentive plan's permission to grant performance awards does not prove that every authorized share has already been awarded or earned.[P][Q1]

The frozen-count illustration deliberately does not pretend to be fully diluted. New awards, exercises, acquisitions and future fundraising could change the denominator. Such changes would need their corresponding consideration or economic cost, not arbitrary extra dilution combined with a pro-rata cash contribution from an investor who supposedly did not participate. No unobserved capital call enters the model.

5.2 Equal cash participation does not mean equal control or liquidity

At the IPO, Class A carried one vote per share and Class B ten; Class C was authorized without votes. The co-founder groups' retained voting position therefore differed substantially from their economic share. Those are governance rights, not ten times the cash entitlement in the allocation calculation.[P][Q1]

Beneficial ownership also is not immediately saleable inventory. The prospectus's lock-ups and market-standoff provisions had defined periods, possible releases and exceptions. Exercisable options can appear in a holder's beneficial count without already being issued cash-equivalent shares. A March pro-forma retention table therefore cannot establish an October 2026 holding, current lock-up, sale receipt or cash available to pay a personal liability.

These differences strengthen neither a blanket reassurance nor a blanket insider-exit narrative. The favorable facts are new company funding and documented liquidity for some holders; the remaining questions concern the price, control, commitments and future costs accepted by continuing investors. The historical put's actual termination is especially important: a proper continuing-claim account must remove expired protection as diligently as it adds newly issued claims.

6. The financing contrast: a repaid bridge, a parent distribution and new secured creditors

6.1 The completed event and its distinct recipients

On May 6, 2026, Core Scientific Finance I LLC, an indirect wholly owned subsidiary, completed a $3.3 billion, 7.75% senior secured note issue due May 15, 2031, priced at 99.25% of face. The closing disclosure estimated approximately $3.24 billion net after discounts and expenses. It specified reserves and a distribution to the parent, with a portion used to retire the recent bridge.[CLOSE]

The later June accounts strengthen the payment status: the MD&A expressly says Finance used net proceeds for a reserve and a distribution to Core Scientific, Inc., and says the $1 billion Term Loan Facility was repaid in full on May 6, including accrued interest and fees. The facility was terminated with no obligations remaining under it at June 30. This is a completed recipient/claim event, not merely a proposed use from a marketing launch.[CSQ]

There are three different beneficiaries. The old term-loan creditors received principal and the contractual amounts necessary to exit. The corporate parent received a subsidiary distribution, part of which serviced that old claim. The new noteholders supplied cash and received a new secured promise. No inspected record makes the subsidiary distribution a dividend to Core Scientific's public shareholders. Nor does the use of Morgan Stanley and JPMorgan in the financing documents establish every lender's retained beneficial position or each institution's realized net income.

The old bridge originated in March and matured 364 days after closing at Term SOFR plus 2.50%. The repayment returned principal; principal is not profit. The exact loan-level interest, fees, creditor acquisition basis, funding cost and allocation among lenders are not disclosed in the inspected cash account. Accordingly, no realized bridge IRR is reported. The transaction establishes successful claim retirement, not the precise after-cost return to every intermediary.

6.2 New sources-and-uses reconciliation: cash, face and costs

The executed issue terms produce $3.27525 billion cash before other fees:

$3.3bn × 99.25% = $3.27525bn.

The $24.75 million original issue discount is the difference between face and issue cash, not extra money received by the borrower or an immediately realized lender gain. The June note records $24.8 million rounded discount and $42 million debt issuance costs as reductions of the carrying amount. That $42 million is an accounting cost observation; it is not, without a cash-timing reconciliation, an exact May closing cash payment.[CSQ]

Subtracting the recorded $42 million from the issue-price cash gives $3.23325 billion, a cost-basis reference. It differs by $6.75 million from the closing disclosure's approximate $3.24 billion estimate. The sources have different precision and status. The difference is retained rather than assigned to an invented fee, rounded away as if audited, or portrayed as missing money.

The new allocation identity is:

Parent net resources after the bridge = $3,275.25m − F − R − $1,000m − I,

where F is cash financing costs for this closing, R is cash retained in the relevant reserve at closing, and I is bridge interest, other expenses and other uses before the stated net-parent boundary. Additional funds retained at the issuer rather than distributed also belong among these uses. The parent can have received a larger gross transfer before applying its part to bridge repayment; gross transfer and net resources are not additive benefits.

The documents report $344.8 million remaining in the debt-service reserve at June 30. That is not the original May deposit, and it cannot be inserted as an observed closing use. The following table is therefore a document-anchored reference, not a claimed settlement statement:

Actual bridge interest and fees were paid. A zero reference for I does not deny them; every additional $1 of such use reduces the residual by $1. An extra $100 million retained or spent before the net-parent boundary would reduce this reference to $1.78845 billion. Differences between the actual closing reserve/cash fees and the proxies can move the result in either direction. Consequently, the $1.88845 billion is not a measured upper bound or lower bound on the transfer.

This advances the capital-recycling account beyond the aggregate proceeds total. It identifies who has first use of the cash, what remains unallocated and exactly how an additional retained resource changes the amount available to the parent. It also prevents treating the difference between $3.3 billion face and $1 billion repaid as $2.3 billion of free cash. The net face increase is $2.3 billion, while the corresponding cash is reduced by discount, costs, protected resources and other uses.

6.3 The distribution was an expressly permitted closing transaction

A new contractual distinction is important for interpreting this capital release. Indenture §4.05(b)(13) permits the one-time Issue Date distribution of offering proceeds as described in the Offering Memorandum. It is separate from the ongoing restricted-payment baskets, including those tied to Final Commencement or retained excess cash flow. Thus, waiting for final service commencement was not a blanket condition for this particular closing distribution.[IND]

That does not eliminate the limits on future extraction. A specific initial distribution permission cannot be reused as unlimited authority to upstream operating collections. Reserve, account, covenant and cash-flow conditions still govern resources within the financed group. The final Offering Memorandum's complete settlement uses and private account certificates were not obtained; the executed indenture and subsequent actual-use statement establish the route, not every wire amount.

This complements, rather than reverses, the completion investigation. Its post-Final-Commencement additional-debt basket is still not funding automatically available to reach that milestone. Here, a different express permission allows a specific closing payment. Applying a single “nothing until completion” rule to both would manufacture a restriction. Applying the closing exception to every later distribution would manufacture liquidity.[COMPLETION]

6.4 What the new lenders and parent retained

The new notes carry first-priority liens over specified financing-company and subsidiary assets, equity in Finance and certain ringfenced rights/assets awaiting transfer. Their guarantees and restrictions do not make the whole corporate group one unrestricted account. The parent provided completion support for specified developments, with the documented Austin exception, rather than a general guarantee of note principal, all tenant payments or every investment outcome.[CLOSE][CSQ][COMPLETION]

The new full-face annual coupon is $255.75 million. Its first scheduled cash payment is November 15, 2026; this chapter does not count that future coupon as a receipt already earned in cash by October 8. Coupon divided by issue-price cash is approximately 7.8086%, a simple cash-coupon ratio—not yield to maturity or realized return. Actual note returns depend on holding period, amortization, redemption, transaction costs and eventual payments.

It is not established that this refinancing lowered the nominal rate. Comparing the new 7.75% coupon with the bridge's SOFR + 2.50% produces equality at 5.25% SOFR. This is a calculated threshold, not an observation of the benchmark rate on either date. The serious favorable case is therefore longer tenor, fixed-rate certainty and repayment of a short bridge, not an unsupported assertion that the new debt was cheaper in every respect.

Customer advances and construction contributions also leave claims through future credits. The company must provide service while some collections are offset. The completion investigation’s matched reimbursement account shows why a receivable need not be a parent-funded hole; it does not make reimbursements discretionary dividends. The joint-cash investigation’s retained-cash identity remains binding: money actually distributed cannot also be retained at the issuer to meet debt amortization or maturity.[CSQ][JOINT][COMPLETION]

The parent retained its own other obligations as well. June accounts identify $460 million of 2029 convertible notes and $625 million of 2031 convertible notes, alongside warrants and other corporate costs. Those claims are not automatically additional secured claims on every Finance I asset, nor are they eliminated by the bridge repayment. A parent-equity return would require their separate conversion/repayment treatment and actual retained capital, which this subsidiary sources-and-uses account does not pretend to value.[CSQ]

6.5 The consolidated check does not turn the residual into parent cash

The half-year group cash account, including restricted cash, conserves the same financing:

$311.378m + $230.949m operating − $1,182.891m investing + $3,191.955m financing = $2,551.391m.

Financing includes $4,275.250 million debt cash receipts, which contain both the original $1 billion bridge draw and $3.27525 billion from the note issue; it then subtracts the $1 billion bridge repayment. The remaining components are −$48.143 million debt-issuance cash costs, −$35.310 million equity tax withholding and +$0.158 million other financing. This broader cost line is not automatically the cash cost of the note issue alone.[CSQ]

Internal subsidiary-to-parent transfers disappear on consolidation. The group account therefore corroborates outside funding and repayment without identifying how much remained usable at each entity. Adding the modeled net-parent residual to consolidated cash would count internal resources twice. Adding past customer advances again while ignoring their credits would do the same to future receipts.

The contrasting risk allocation is now clear. In a secondary sale, a purchaser gives cash to an existing owner and acquires its equity risk without funding the issuer. In this refinancing, new creditors supply issuer cash; an old creditor exits, reserves retain some cash and the parent receives a distribution while future project resources support new debt. Both can be orderly and economically useful. Neither transaction alone creates new end-customer income, and their surviving claimants face materially different priorities and payment obligations.

7. What this changes about the whole bubble question

7.1 Evidence that now deserves greater favorable weight

The strongest new favorable evidence is not a high valuation headline. It is completed cash realization with identifiable counterparties and retained claims. The IPO was largely company funding, not predominantly a contemporaneous insider exit. Earlier secondary buyers supplied documented seller liquidity. The old bridge was actually repaid. A restrictive historical redemption right actually terminated. Each establishes something more concrete than an announcement or a mark-up.[P][Q1][Q3][CSQ]

These events are compatible with productive capital formation. Primary money can pay for capacity and retire a short-dated loan. Secondary liquidity can compensate early risk-taking and reduce excessive concentration without removing operating assets. Longer-term secured debt can replace a bridge while leaving useful capital for the parent. A successful market-price condition can remove a contingent redemption burden without a cash drain. No evidence here justifies dismissing such outcomes as fictitious because new investors helped finance them.

The broader operating evidence makes that explanation credible rather than purely financial. The accepted work documents real buyer decisions, selective continuing use of older capacity and legitimate completion-financing routes. The efficiency investigation provides a measurable way for technical efficiency to leave resources for continuing costs, while retaining its demand and quality limits. These findings allow service, supplier and investor success to coexist; the financial transactions need not be compensating for an empty operating economy.[COMPLETION][BUYERS][EFFICIENCY][PRIOR]

7.2 The serious adverse case is a price-and-claim mismatch, not the word “recycling”

The new adverse mechanism is more precise. An old investor can recover cash before the business's full investment bill has been paid from operations; a new investor then owns the remaining execution and valuation risk. The named cost-basis comparison shows why even a common share with identical future cash can yield opposite investment results. The historical floor shows a further contractual difference in who would have absorbed a weak sale value.

Similarly, debt-funded parent resources can coexist with a larger financed claim on future cash. Ongoing customer payments must cover delivery, credits, maintenance, interest and required retained resources before residual distributions can safely do another job. In the completion investigation, the timing and eligibility of completion resources matter. In the buyer-budget investigation, a rational purchase can mainly replace an existing budget, so its whole benefit is not net new supplier revenue. In the efficiency investigation, a cheap component leaves a finite budget for quality, development and support rather than proving a full margin. None of these constraints is lifted because a prior holder sold successfully.[JOINT][COMPLETION][BUYERS][EFFICIENCY]

The observed facts do not establish that a particular new buyer overpaid, that the secured notes will fail, or that secondary recipients engaged in misconduct. The conditional allocation shows how losses could differ; it supplies no probability that its low value will occur. Equally, the high-value case is not guaranteed simply because the financing closed. An explanation that treats all successful fundraising as validation of the price is as incomplete as one that treats all fundraising dependence as failure.

7.3 Current judgment and discriminating evidence

The pool's answer should give greater weight to real financial realization and workable capital recycling, while locating the remaining bubble vulnerability in prices and claims that may require more future cash than the operating chain can retain. This chapter weakens blanket “all paper gains,” “every financing is an insider cash-out” and “new money proves nothing useful” accounts. It does not establish that all ownership expectations are supported. The stronger conclusion is that realized gains, sustainable operating returns and a justified later entry price must be measured separately at the actual claim.

The favorable judgment would strengthen further with matched post-completion collections after credits, demonstrated recurring cash after replacement and development, and creditor repayment without an increasingly expensive or senior financing burden. The adverse interpretation would strengthen with repeated extraction that demonstrably leaves required costs unfunded, adverse repricing of comparable newly assumed claims, or measured full-cost cash persistently below the requirements embedded in prices. A new primary round with more demanding rights could also change the result even if its headline valuation rose. These are specific observations capable of changing the assessment, not a requirement to wait for an industry-wide collapse.

Coverage remains limited. CoreWeave and Core Scientific are connected counterparties, not two independent samples of the AI economy. GECC adds a holder viewpoint but not an industry census. This report does not measure the fraction of all AI equity that is overpriced, the prevalence of refinancing risk, or a system-wide loss amount. Further ownership analysis can use these claim and realization distinctions, but the conditional sale values and parent-resource reference are not observed assets.

8. Methods, continuity and remaining limits

8.1 What is newly established and what is inherited

The new documentary work uses the final IPO prospectus and subsequent quarterly accounts to join primary proceeds, seller receipts, cost timing, conversion rights and later termination. It adds a named seller's documented exercise deduction, a precise disclosed acquisition basis, a conserved company-sale allocation, and a final-term debt-recapitalization account with a distinct closing distribution permission. The result does not depend on an assumed future IPO or private LP portfolio access.

The earlier holder, joint-cash, completion, buyer-budget and efficiency investigations are inherited findings, not rediscovered evidence. Their own measurement periods and qualifications remain controlling; this chapter does not independently refresh them.

The controlling corrections remain unchanged. NVIDIA–Energy Global is obligation established, receipt unverified; nonpayment not inferred. The completion investigation’s source-status resolution keeps April's 8.25% illustration separate from May's executed 7.75% coupon. The later CoreWeave September 2026 closing remains a dated completed financing, not current unspent cash. Nothing in the March 2025 IPO reconstruction silently rewrites those different observations.[PRIOR]

8.2 What the calculations can and cannot establish

The companion uses exact decimal inputs and checks conservation, units, evidence statuses and explicit domain boundaries. Its output is reproducible from realization-data.csv, with an explicit --data option. Standard output contains the calculated results and check summary; no network access, paid service, plotting library or predecessor file is required. Run:

python realization-calculations.py --data realization-data.csv

There are no probability estimates or portfolio recommendations. The rights cases freeze a historical share structure; the refinancing reference intentionally leaves exact closing costs and reserve movements unresolved. Some filing quantities are rounded even where arithmetic produces more digits. Displayed precision is for tracing and reconciliation, not a claim to a more precise economic measurement.

A successful script does not validate the filing's internal descriptions, a missing private wire or a hypothetical exit. The numerical checks test the implementation, not missing payments, private costs or the likelihood of the illustrative outcomes.

8.3 Consequential unavailable evidence

The most consequential limits are the missing seller tax and full investment bases, ultimate fund-investor distributions, complete May settlement-account allocation, and current fully diluted ownership/cost accounts. Holder-specific bank records and the private LP portfolio were not available. The IPO option's $759,800 reconciliation, preferred-dividend quarter allocation and a tender's conflicting McVeety row remain explicitly unresolved. No missing item is silently set to zero.

The original prospectus was read selectively in its relevant final-term, financial, related-party, selling-holder and capital-rights sections, with successful PDF screenshots of consequential tables and rights pages. This was not a claim to visually audit all 340 pages. The quarterly reports and indenture were inspected as original filed HTML. No private contact, paid acquisition, transaction execution or source request for confidential information was undertaken.

These limitations prevent complete individual IRRs and a fully reconciled closing bank account. They do not erase the documented offering, reported seller receipts, historical rights termination or completed bridge repayment. The transaction-level findings and the unresolved allocations must be retained together.